Table 2.
Autoantibody specificities detected in sera from Oklahoma tribal patients referred to the rheumatic disease clinic.
| RA n=40 |
SLE n=16 |
SSc n=8 |
SS n=1 |
PA n=11 |
pa n=11 |
FM n= 4 |
OA n=8 |
Other n= 11 |
|
|---|---|---|---|---|---|---|---|---|---|
| ANA | 25* | 11 | 7 | 1 | 8 | 5 | 2 | 5† | 5‡ |
| Anti-dsDNA | 1 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| aCLs IgG | 10 | 2 | 3 | 0 | 5 | 1 | 2 | 1 | 3§ |
| aCLs IgM | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1†† |
| Anti-Ro | 2* | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Anti-La | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Anti-Sm | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1†† |
| Anti-nRNP | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1** |
| Anti-Ribo P | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Anti-Jo 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Unidentified | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Anti-CCP | 22 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1†† |
| Anti-RF IgM | 23 | 1 | 1 | 1 | 1 | 2 | 0 | 1 | 0 |
| Anti-RF IgG | 12 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 |
PA = Polyarthritis; pa = polyarthralgia; FM = Fibromyalgia; OA = Osteoarthritis
Other =UCTD (4), Anterior Uveitis (3), Sarcoidosis (1), Sclerodactyly (1), Seronegative SpA (2)
*
= Patient with both RA and Sjogren’s (1)
†
= Patient with both FM and OA (2)
‡
= UCTD (3) and Anterior Uveitis (1)
§
= UCTD (2) and Sclerodactly (1)
††
= UCTD (1)
**
= Inflammatory Eye Disease
Unidentified = antibody binding lines detected during immunodiffusion that do not match known rheumatic disease antigens